Vimarsana
Biggest News Aggregation in the World

Programmed Cell Death News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Programmed Cell Death. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Programmed Cell Death Today - Breaking & Trending Today

Study reveals key protein's role in balancing immune response to viral infections - Vimarsana News

Study reveals key protein's role in balancing immune response to viral infections

Researchers have revealed the regulatory mechanism of a specific protein that plays a key role in balancing the immune response triggered by viral infections in mammal cells.

Comprehensive analysis of immune checkpoint inhibitors reveals endocrine toxicity patterns - Vimarsana News

Comprehensive analysis of immune checkpoint inhibitors reveals endocrine toxicity patterns

Announcing a new publication for Acta Materia Medica journal. Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment but pose a challenge of immune-related adverse events (irAEs), particularly endocrine toxicity, that can severely compromise patient well-being.

Study finds marijuana can kill skin cancer cells — but there are some big caveats - Vimarsana News

Study finds marijuana can kill skin cancer cells — but there are some big caveats

The skin cancer cells self-destructed, the study said.

Source: yahoo.com
Study demonstrates chemo-preventive properties of alpha-santalol against prostate cancer development - Vimarsana News

Study demonstrates chemo-preventive properties of alpha-santalol against prostate cancer development

Extracted from the core of sandalwood trees (santalum album tree), sandalwood oil has been used for many centuries by several cultures throughout the world for perfume, soaps, incense and candles.

Advanced melanoma survival rates improve significantly from 2013 to 2019, Dutch study finds - Vimarsana News

Advanced melanoma survival rates improve significantly from 2013 to 2019, Dutch study finds

The change in overall survival (OS) among advanced melanoma patients diagnosed between 2013 and 2021.